Rituximab Maintenance Treatment of Relapsed/Resistant Follicular Non-Hodgkin's Lymphoma: Long-Term Outcome of the EORTC 20981 Phase III Randomized Intergroup Study

PURPOSE: In 2006, we published the results of the European Organisation for Research and Treatment of Cancer phase III trial EORTC 20981 on the role of rituximab in remission induction and maintenance treatment of relapsed/resistant follicular lymphoma (FL). At that time, the median follow-up for th...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: van Oers, Marinus H.J., Van Glabbeke, Martine, Giurgea, Livia, Klasa, Richard, Marcus, Robert E., Wolf, Max, Kimby, Eva, van t Veer, Mars, Vranovsky, Andrej, Holte, Harald, Hagenbeek, Anton
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903319/
https://ncbi.nlm.nih.gov/pubmed/20439641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.5827
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares